Saturn V Capital Management LP

13D and 13G Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
Monopar Therapeutics 13G/A MNPR · 61023L207	MNPR	61023L207	4.7%	313,384	13G/A	8/12/2026 Event 6/30/2026
Saturn V Capital Management LP			4.7%	313,384
Xiaoying Tian			4.7%	313,384
Immix Biopharma, Inc. 13G IMMX · 45258H106	IMMX	45258H106	7.0%	3,693,585	13G	2/17/2026 Event 12/26/2025
Saturn V Capital Management LP			7.0%	3,693,585
Xiaoying Tian			7.0%	3,693,585
X4 Pharmaceuticals, Inc. 13G XFOR · 98420X202	XFOR	98420X202	7.4%	6,433,481	13G	2/17/2026 Event 10/24/2025
Saturn V Capital Management LP			7.4%	6,433,481
Xiaoying Tian			7.4%	6,433,481